Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic

The number of cases of the coronavirus-induced disease-2019 (COVID-19) continues to increase exponentially worldwide. In this crisis situation, the management of ST-segment elevation myocardial infarction (STEMI) is challenging. In this review, we outline the risks and benefits of primary PCI vs. th...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cardiovasc Revasc Med
Auteurs principaux: Yerasi, Charan, Case, Brian C., Forrestal, Brian J., Chezar-Azerrad, Chava, Hashim, Hayder, Ben-Dor, Itsik, Satler, Lowell F., Mintz, Gary S., Waksman, Ron
Format: Artigo
Langue:Inglês
Publié: Elsevier Inc. 2020
Sujets:
Reviews
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7241397/
https://ncbi.nlm.nih.gov/pubmed/32471712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.carrev.2020.05.027
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires